Cannabis-based products for pediatric epilepsy: An updated systematic review
Purpose
To provide an up-to-date summary of the benefits and harms of cannabis-based products for epilepsy in children.
Purpose
To provide an up-to-date summary of the benefits and harms of cannabis-based products for epilepsy in children.
The objective of this observational study was to evaluate the efficacy of medical cannabis for the treatment of refractory epilepsy. Fifty-seven patients (age 1-20 years) with epilepsy of various etiologies were treated with Cannabis oil extract (CBD/THC ratio of 20:1) for at least 3 months (Median follow up time-18 months).